Log in

Relevant bibliographies by topics / Structure-activity relationship (Pharmacology)

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Structure-activity relationship (Pharmacology)'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Structure-activity relationship (Pharmacology).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Structure-activity relationship (Pharmacology)"

1

Sukamoto, Takayuki, and Tadayuki Saito. "The structure-activity relationship of anti-histamines." Japanese Journal of Pharmacology 71 (1996): 18. http://dx.doi.org/10.1016/s0021-5198(19)36336-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Topal, Fevzi, Meryem Nar, Hulya Gocer, et al. "Antioxidant activity of taxifolin: an activity–structure relationship." Journal of Enzyme Inhibition and Medicinal Chemistry 31, no. 4 (2015): 674–83. http://dx.doi.org/10.3109/14756366.2015.1057723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wu, Tao, Osafo Raymond Kwaku, Hai-Zhou Li, Chong-Ren Yang, Long-Jiao Ge, and Min Xu. "Sense Ginsenosides From Ginsengs: Structure-Activity Relationship in Autophagy." Natural Product Communications 14, no. 6 (2019): 1934578X1985822. http://dx.doi.org/10.1177/1934578x19858223.

Full text

Abstract:

The term ginseng refers to the dried roots of several plants belonging to the genus Panax of the Araliaceae family. The 3 major commercial ginsengs are Panax notoginseng (Burk.) F.H. Chen (Notoginseng), P. ginseng C.A. Meyer (Ginseng), and P. quinquefolius L. (American ginseng), which have been used as herbal medicines. Over 18,000 papers on ginsengs have been published on the basis of their structural diversity and biological activities. Many reviews have summarized the phytochemistry, pharmacology, and clinical use of ginsengs, but the structure-activity relationship (SAR) of ginsenosides fr

APA, Harvard, Vancouver, ISO, and other styles

4

Shih-Fong, Chen, Lisa M. Papp, Robert J. Ardecky, et al. "Structure-activity relationship of quinoline carboxylic acids." Biochemical Pharmacology 40, no. 4 (1990): 709–14. http://dx.doi.org/10.1016/0006-2952(90)90305-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Wawer, Mathias J., David E. Jaramillo, Vlado Dančík, et al. "Automated Structure–Activity Relationship Mining." Journal of Biomolecular Screening 19, no. 5 (2014): 738–48. http://dx.doi.org/10.1177/1087057114530783.

Full text

Abstract:

Understanding the structure–activity relationships (SARs) of small molecules is important for developing probes and novel therapeutic agents in chemical biology and drug discovery. Increasingly, multiplexed small-molecule profiling assays allow simultaneous measurement of many biological response parameters for the same compound (e.g., expression levels for many genes or binding constants against many proteins). Although such methods promise to capture SARs with high granularity, few computational methods are available to support SAR analyses of high-dimensional compound activity profiles. Man

APA, Harvard, Vancouver, ISO, and other styles

6

TAKAGI, Kenzo, Takaaki HASEGAWA, Takafumi KUZUYA, et al. "Structure-Activity Relationship in N3-Alkyl-Xanthine Derivatives." Japanese Journal of Pharmacology 46, no. 4 (1988): 373–78. http://dx.doi.org/10.1016/s0021-5198(19)43290-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

TAKAGI, Kenzo, Takaaki HASEGAWA, Takafumi KUZUYA, et al. "Structure-activity relationship in N3-alkyl-xanthine derivatives." Japanese Journal of Pharmacology 46, no. 4 (1988): 373–78. http://dx.doi.org/10.1254/jjp.46.373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Betelina, I. B., L. A. Tyurina, S. A. Kirlan, et al. "Structure-biological activity relationship in prostaglandin analogs." Pharmaceutical Chemistry Journal 40, no. 8 (2006): 424–29. http://dx.doi.org/10.1007/s11094-006-0145-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

MIURA, Toshihiro, Yumi NISHIYAMA, Momoyo ICHIMARU, Masataka MORIYASU, and Atsushi KATO. "HYPOGLYCEMIC ACTIVITY AND STRUCTURE-ACTIVITY RELATIONSHIP OF IRIDOIDAL GLYCOSIDES." Biological & Pharmaceutical Bulletin 19, no. 1 (1996): 160–61. http://dx.doi.org/10.1248/bpb.19.160.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Dvoryantseva, G. G., S. V. Lindeman, Yu T. Struchkov, et al. "Structure-activity relationship in ?-carboline derivatives. Molecular structure of Inkasan." Pharmaceutical Chemistry Journal 19, no. 12 (1985): 822–31. http://dx.doi.org/10.1007/bf01148378.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Structure-activity relationship (Pharmacology)"

1

Diaz-Perez, Maria-Jose. "Quantitative structure-activity relationship (QSAR) study of the effect of steroids on DNA replication." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/NQ50291.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Peron, Jean-Marie. "Quantitative structure activity relationship analysis of anti-oxidants with central nervous system therapeutic potential." Thesis, King's College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271327.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Davies, Rachel A. "Structure-Activity Relationship Studies of Synthetic Cathinones and Related Agents." VCU Scholars Compass, 2019. https://scholarscompass.vcu.edu/etd/5953.

Full text

Abstract:

Synthetic cathinones and related agents represent an international drug abuse problem, and at the same time an important class of clinically useful compounds. Structure-activity relationship studies are needed to elucidate molecular features underlying the pharmacology of these agents. Illicit methcathinone (i.e., MCAT), the prototype of the synthetic cathinone class, exists as a racemic mixture. Though the differences in potency and target selectivity between the positional and optical isomers of synthetic cathinones and related agents have been demonstrated to have important implications for

APA, Harvard, Vancouver, ISO, and other styles

4

Nilsson, Ulrika K. "Lysophosphatidic acid : Physiological effects and structure-activity relationships." Doctoral thesis, Linköping : Univ, 2002. http://www.ep.liu.se/diss/med/07/51/index.html.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

MilitÃo, GardÃnia Carmen Gadelha. "Antitumor potential of flavonoids derived from northeastern brazilian plants: preliminary studies on structure-cytotoxic activity relationship." Universidade Federal do CearÃ, 2005. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=100.

Full text

Abstract:

CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior<br>In searching for anticancer compounds derived from plant sources, 18 flavonoids were assayed for their cytotoxic potentials and the results were compared for structure-activity relationship purposes. The flavonoid group was subdivided in flavones and pterocarpans. The cytotoxic activity was initially evaluated on tumor cell lines, through the MTT assay, and on sea urchin eggs development. The pterocarpans showed a consistently higher activity on both assays. For the flavones, some structure-activity observations can be highlighted:

APA, Harvard, Vancouver, ISO, and other styles

6

Bonano, Julie S. "Structural Determinants of Abuse-Related Neurochemical and Behavioral Effects of Para-Substituted Methcathinone Analogs in Rats." VCU Scholars Compass, 2015. http://scholarscompass.vcu.edu/etd/3911.

Full text

Abstract:

Methcathinone (MCAT) is the β-ketone analog of methamphetamine, and like its amphetamine analog, MCAT functions as a monoamine releaser that selectively promotes the release of dopamine (DA) and norepinephrine (NE) over serotonin (5-HT). MCAT produces amphetamine-like psychostimulant effects and is classified as a Schedule I drug of abuse by the United States Drug Enforcement Administration (DEA). Recently, synthetic MCAT analogs have emerged as designer drugs of abuse in Europe and the United States and have been marketed under deceptively benign names like “bath salts” in an attempt to evade

APA, Harvard, Vancouver, ISO, and other styles

7

Al-Baghdadi, Osamah Basim Khalaf. "Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson’s disease." Kent State University / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=kent1413741660.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Odhar, Hasanain. "Identification of novel scaffolds for Monoamine oxidase B inhibitors." Kent State University / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=kent1394416913.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

McFadyen, Iain James. "Structure-activity relationships of opioid ligands." Thesis, Loughborough University, 1999. https://dspace.lboro.ac.uk/2134/33189.

Full text

Abstract:

There are three different types of opioid receptor, namely mu, delta and kappa. Morphine and related clinically useful analgesics exert their actions through the mu opioid receptor. Such compounds represent a huge structural diversity, including both peptides and alkaloids. Nevertheless, there exists a common pharmacophore comprising two critical features, namely an amine nitrogen and an aromatic ring, usually with a hydroxyl substituent; the spatial relationship between them is also vital.

APA, Harvard, Vancouver, ISO, and other styles

10

Morsman, Janine M. "Structure-activity relationships (SAR) for cytochrome P4502C9." Thesis, University of Aberdeen, 1999. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU536139.

Full text

Abstract:

In this project, an SAR approach was used to assess the putative active site interactions, using analogues of phenytoin (a co-regulated substrate), sulfaphenazole (CYP2C9-specific inhibitor) and bis-triazole antifungals (thought to exhibit less specific inhibition). <I>K</I><SUB>i</SUB> values were determined for the inhibition of tolbutamide methylhydroxylation. N2 of phenytoin is a postulated H-bond donor. Substitution (CH<SUB>3</SUB> or NH<SUB>2</SUB>), reduced inhibitory potency from 46 μM to 74 μM and 98 μM, respectively. Inhibition was competitive. Removal of a phenyl ring removed inhibi

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Structure-activity relationship (Pharmacology)"

1

Predrag, Cudic. Peptide modifications to increase metabolic stability and activity. Humana Press, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pandi, Veerapandian, ed. Structure-based drug design. Marcel Dekker, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Francesco, Parenti, and Gallo Gian Gualberto, eds. Antibiotics: A multidisciplinary approach. Plenum Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Avdeef, Alex. Absorption and drug development: Solubility, permeability, and charge state. 2nd ed. John Wiley & Sons, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ramalho, Merce Ana Lucia, Felcman Judith, and Recio Maria Angeles Lobo, eds. Molecular and supramolecular bioinorganic chemistry: Applications in medical sciences. Nova Science Publishers, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

M, Beart P., Woodruff G. N, Jackson D. M, and International Congress of Pharmacology, (10th : 1987 : Sydney, N.S.W.), eds. Pharmacology and functional regulation of dopaminergic neurons: Proceedings of a satellite symposium of the IUPHAR 10th International Congress of pharmacology, 31 Aug.- 2 Sep. 1987. Macmillan, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

author, Panaye Annick, ed. Three dimensional QSAR: Applications in pharmacology and toxicology. CRC Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Biochemical Pharmacology Symposium (4th 1989 New Haven, Conn.). NMR methods for elucidating macromolecule-ligand interactions: An approach to drug design : proceedings of the Fourth Biochemical Pharmacology Symposium, New Haven, CT, 27-29 July 1989. Edited by Handschumacher Robert E, Armitage Ian M, and Welch Arnold D. Pergamon Press, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Alexandros, Makriyannis, and Biegel Diane 1952-, eds. Drug discovery strategies and methods. Marcel Dekker, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

1956-, Devillers J., ed. Endocrine disruption modeling. Taylor & Francis, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Structure-activity relationship (Pharmacology)"

1

Hong, Huixiao, Jieqiang Zhu, Minjun Chen, Ping Gong, Chaoyang Zhang, and Weida Tong. "Quantitative Structure–Activity Relationship Models for Predicting Risk of Drug-Induced Liver Injury in Humans." In Methods in Pharmacology and Toxicology. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7677-5_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Jin, G. Z., K. X. Huang, W. D. Le, and S. X. Xu. "Structure-Activity Relationship of Tetrahydroprotoberberines on Central Dopamine Receptors: (−)-Stepholidine—a New Antagonist of Dopamine Receptors." In Pharmacology and Functional Regulation of Dopaminergic Neurons. Palgrave Macmillan UK, 1988. http://dx.doi.org/10.1007/978-1-349-10047-7_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lakshmanan, Mageshwaran. "Structure-Activity Relationships." In Introduction to Basics of Pharmacology and Toxicology. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-32-9779-1_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Büttner, Andreas, and Detlef Thieme. "Side Effects of Anabolic Androgenic Steroids: Pathological Findings and Structure–Activity Relationships." In Handbook of Experimental Pharmacology. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-79088-4_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Barnett, Allen, Robert McQuade, and Richard Chipkin. "Structure-Activity Relationships for Benzazepines as D1-Specific Dopamine Antagonists." In Pharmacology and Functional Regulation of Dopaminergic Neurons. Palgrave Macmillan UK, 1988. http://dx.doi.org/10.1007/978-1-349-10047-7_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Aher, Rahul Balasaheb, Kabiruddin Khan, and Kunal Roy. "A Brief Introduction to Quantitative Structure-Activity Relationships as Useful Tools in Predictive Ecotoxicology." In Methods in Pharmacology and Toxicology. Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0150-1_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ebbrell, David J., Mark T. D. Cronin, Claire M. Ellison, James W. Firman, and Judith C. Madden. "Development of Baseline Quantitative Structure-Activity Relationships (QSARs) for the Effects of Active Pharmaceutical Ingredients (APIs) to Aquatic Species." In Methods in Pharmacology and Toxicology. Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0150-1_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Cronin, Mark. "The Prediction of Skin Permeability Using Quantitative Structure–Activity Relationship Methods." In Dermal Absorption Models in Toxicology and Pharmacology. CRC Press, 2005. http://dx.doi.org/10.1201/9780203020821.ch7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Clausen, Rasmus Prætorius, Karsten Madsen, Orla Miller Larsson, Bente Frølund, Povl Krogsgaard‐Larsen, and Arne Schousboe. "Structure–Activity Relationship and Pharmacology of γ‐Aminobutyric Acid (GABA) Transport Inhibitors." In GABA. Elsevier, 2006. http://dx.doi.org/10.1016/s1054-3589(06)54011-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Stäuble, Christiane G., Heidrun Lewald, and Manfred Blobner. "Neuromuscular Junction." In Oxford Textbook of Neuroscience and Anaesthesiology, edited by George A. Mashour and Kristin Engelhard. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198746645.003.0006.

Full text

Abstract:

This chapter outlines an introduction to the neuromuscular junction. It covers anatomy and physiology (including presynaptic physiology and pharmacology, postsynaptic physiology and pharmacology, and margin of safety of neurotransmission), paralytics, reversal agents, the mechanisms of action of muscle relaxants (and their structure-activity relationship, intrinsic activity at the neuromuscular junction, effects on acetylcholine receptors of the CNS/ANS, the carotid body, bronchial smooth muscle, and histamine release and anaphylaxis by relaxants), and the acetylcholinesterase enzyme. The chap

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Structure-activity relationship (Pharmacology)"

1

Davydova, N. K. "«STRUCTURE – ACTIVITY» RELATIONSHIP OF ANTIARRHYTHMIC DRUGS NIBENTAN AND NIFERIDYL." In NOVEL TECHNOLOGIES IN MEDICINE, BIOLOGY, PHARMACOLOGY AND ECOLOGY. Institute of information technology, 2022. http://dx.doi.org/10.47501/978-5-6044060-2-1.123-126.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!